Pfizer
Top Five Articles on 360Dx Last Week: Qiagen, BioMérieux Lawsuit; T2 Biosystems Post-Mortem; More
Last week, readers were most interested in a story about a lawsuit brought forth by Qiagen against BioMérieux in Germany.
Top Five Articles on 360Dx Last Week: Pfizer Shutting Down Lucira Health Business; More
Last week, readers were most interested in a story about Pfizer shuttering the Lucira Health business that it acquired in 2023.
The pharmaceutical firm said the decision was related to the cost associated with the molecular tests.
BioMérieux, Pfizer, Malawi Ministry of Health Collaborate on Antimicrobial Resistance Effort
The effort will supply four central hospitals with diagnostics and training to support antimicrobial stewardship initiatives.
Labcorp Receives FDA Approval for CDx for Pfizer Hemophilia B Gene Therapy
The test is a cell-based neutralizing antibody assay that detects preexisting anti-AAVRh74var antibodies that could impact patient safety or the efficacy of treatment.
Dec 11, 2023
Jan 20, 2022
Jan 18, 2022
Sema4 to Acquire GeneDx for $623M
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Feb 24, 2020